- Home
- NDRA vs ALZN Comparison
NDRA vs ALZN Comparison
Compare NDRA & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- ALZN
- Stock Information
- Founded
- NDRA 2007
- ALZN 2016
- Country
- NDRA United States
- ALZN United States
- Employees
- NDRA N/A
- ALZN N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- NDRA Health Care
- ALZN Health Care
- Exchange
- NDRA Nasdaq
- ALZN Nasdaq
- Market Cap
- NDRA 2.3M
- ALZN 2.3M
- IPO Year
- NDRA 2017
- ALZN 2021
- Fundamental
- Price
- NDRA N/A
- ALZN $2.91
- Analyst Decision
- NDRA Strong Buy
- ALZN Strong Buy
- Analyst Count
- NDRA 1
- ALZN 1
- Target Price
- NDRA $46.00
- ALZN $180.00
- AVG Volume (30 Days)
- NDRA 24.9K
- ALZN 436.9K
- Earning Date
- NDRA 08-13-2025
- ALZN 07-29-2025
- Dividend Yield
- NDRA N/A
- ALZN N/A
- EPS Growth
- NDRA N/A
- ALZN N/A
- EPS
- NDRA N/A
- ALZN N/A
- Revenue
- NDRA N/A
- ALZN N/A
- Revenue This Year
- NDRA N/A
- ALZN $322.64
- Revenue Next Year
- NDRA N/A
- ALZN N/A
- P/E Ratio
- NDRA N/A
- ALZN N/A
- Revenue Growth
- NDRA N/A
- ALZN N/A
- 52 Week Low
- NDRA $2.90
- ALZN $2.75
- 52 Week High
- NDRA $179.20
- ALZN $135.54
- Technical
- Relative Strength Index (RSI)
- NDRA 50.85
- ALZN 38.28
- Support Level
- NDRA $3.41
- ALZN $2.81
- Resistance Level
- NDRA $3.70
- ALZN $3.05
- Average True Range (ATR)
- NDRA 0.21
- ALZN 0.17
- MACD
- NDRA 0.05
- ALZN 0.07
- Stochastic Oscillator
- NDRA 71.43
- ALZN 27.94
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.